We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants More Safety Data Before Approving Pargluva
FDA Wants More Safety Data Before Approving Pargluva
October 21, 2005
Merck and Bristol-Myers Squibb (BMS) must submit additional safety data to the FDA before their jointly developed diabetes drug Pargluva can gain final approval, the firms said Oct. 18.